Acute unilateral anterior uveitis and scleritis following a single infusion of zoledronate for metastatic breast cancer.
Moore
Melissa M
MM
Medical Oncology, Royal Prince Alfred Hospital, Sydney, NSW, Australia. mmm@med.usyd.edu.au
Beith
Jane M
JM
D000208:Acute Disease; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D001859:Bone Neoplasms / Q000188:drug therapy* / Q000556:secondary*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology*; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy / Q000473:pathology*; D004164:Diphosphonates / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D008875:Middle Aged; D015423:Scleritis / Q000139:chemically induced*; D014606:Uveitis, Anterior / Q000139:chemically induced*; D000077211:Zoledronic Acid
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D007093:Imidazoles; D000077211:Zoledronic Acid